For the second year in a row, the antiviral drug Kagocel has been named # 1 Russian brand in the retail market. At the ceremony of awarding the leaders of the National Pharmaceutical Rating held on January 29, Kagocel once again confirmed its well-deserved status among the expert community.
The National Pharmaceutical Rating has been distinguishing the best of the best in the pharmaceutical industry for 4 years in a row. Entering the stage for awards are representatives of leading companies whose products are in demand among patients and doctors, and the expert community recognizes them as the best on the market.
For more than 15 years of its existence, Kagocel has established itself as an effective and safe drug that fights flu and ARVI, has an extensive evidence base, and a history of research totalling the participation of more than 23,000 patients aged 3 to 93 years.